Biotech Startups

Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.

2 investors

Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

2 investors

Highlight Therapeutics is a biotech company developing therapeutic treatments. The page does not provide specific details about the company's focus area, customer base, or geographic market.

2 investors

Hijack Bio develops targeted biogenic drug delivery systems with environmental awareness. The company operates in the biotech and pharmaceutical delivery sector.

2 investors

HLB Panagene develops molecular diagnostics and immunodiagnostics solutions, including cancer biomarkers and respiratory/cardiovascular tests for precision medicine and point-of-care applications. The company serves healthcare systems and diagnostics markets primarily in the Middle East and is expanding into GCC countries and Europe.

2 investors

Holiferm develops and produces performance ingredients using biomanufacturing and fermentation, supplying biosurfactants for use in personal care, cosmetics, and household cleaning products. Its ingredients are used by consumer brands in products such as cleansers, shower foams, surface cleaners, and shampoo bars.

2 investors

HILO is a Hokkaido University spin-out commercializing a drug-efficacy evaluation method based on fluorescence bioimaging technology developed by Professor Yusuke Ohba. The company operates a registered clinical testing laboratory and serves pharmaceutical research and development applications.

2 investors

HoX develops hardware, software, and chemistry capabilities to integrate biological analysis into business and health applications. The company operates an integrated system that connects biological samples, data, and analysis tools for faster biological insights.

2 investors

HutanBio develops marine microalgae-derived biofuels for decarbonizing heavy transport, using industrial-scale production platforms deployed on non-arable land without freshwater consumption. The company's technology is designed to provide low-carbon sustainable fuel alternatives while protecting ecosystems and food systems.

2 investors

HVR Cardio develops medical devices for cardiovascular applications, drawing on a management team with combined expertise in structural heart technologies and medical device commercialization.

2 investors

Hylomorph is a medical device company developing Vesta, a product in the cardiac/implantable device area, working with clinical partners such as Penn Medicine, Sant'Orsola Hospital, and the German Heart Center Charité. The company is headquartered at Technopark Zurich.

2 investors

HypaHub developed a data and AI platform for multiomic analysis to support biomarker discovery and drug development in biotechnology and life sciences. The platform has been acquired by GaudiBio and is now part of their offerings.

2 investors

Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.

2 investors

Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)

2 investors

Hyris provides diagnostic testing solutions and marketplace technology for healthcare facilities and agricultural operations, enabling distributed testing networks managed from a central hub and pathogen detection services.

2 investors

IASO Therapeutics develops synthetic antigen vaccines using a mutant Qβ virus-like particle carrier platform to generate targeted, durable immunity. The company focuses on next-generation vaccines for infectious disease prevention, including combating antimicrobial resistance.

2 investors

iCarbonX (碳云智能) is a digital life company using artificial intelligence and silicon-based biochip technology for drug discovery, precision diagnostics, and innovation across genomics, proteomics, and digital health. Founded in 2015 and based in Shenzhen, China, it develops next-generation healthcare technologies including its silicon-based in-situ synthesis biochips.

2 investors

Ichora develops crop protection fungicide solutions using repurposed molecules with antimicrobial properties to address resistant plant pathogens. The company targets agricultural producers seeking effective alternatives to conventional fungicides.

2 investors

iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.

2 investors

Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.

2 investors

Idience is a biopharmaceutical company focused on developing and commercializing new medicines. Established in 2019 as a wholly owned subsidiary of Korean pharmaceutical group Ildong Holdings.

2 investors

Acquired by Pfizer (NYSE: PFE)

2 investors

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. Its focus is on drug candidates with differentiated clinical profiles.

2 investors

Ikerian applies data and AI to identify biomarkers linked to chronic and systemic disorders, aggregate clinical insights, and support treatment decisions. The company serves healthcare stakeholders and drug developers by curating information and optimizing clinical workflows and operations.

2 investors